Prolactin-Producing Pituitary Tumor

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Recordati
RecordatiFrance - Saint-Victor
1 program
1
PasireotidePhase 2Peptide1 trial
Active Trials
NCT06295952Recruiting10Est. Feb 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
RecordatiPasireotide

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

A Study of Pasireotide in People With Prolactinoma

Start: Feb 2024Est. completion: Feb 202710 patients
Phase 2Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 10 patients
1 companies competing in this space